4/A
Changes in Ownership
CASTLE BIOSCIENCES INC Filed Acc 0001628280-25-052350
Chief Commercial Officer sold 700 shares at an average $35.39 ($24,775)
- Chief Commercial Officer acquired 700 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Juvenal Tobin W Chief Commercial Officer | 2025-11-11 | Option exercise 10b5-1 | +500 | $3.38 | $1,690 | 85,027 | D |
| Juvenal Tobin W Chief Commercial Officer | 2025-11-11 | Sale 10b5-1 | −500 | $35.39 | $17,695 | 84,527 | D |
| Juvenal Tobin W Chief Commercial Officer | 2025-11-12 | Option exercise 10b5-1 | +200 | $3.38 | $676 | 84,727 | D |
| Juvenal Tobin W Chief Commercial Officer | 2025-11-12 | Sale 10b5-1 | −200 | $35.40 | $7,080 | 84,527 | D |
| Derivatives | |||||||
| Juvenal Tobin W Chief Commercial Officer | 2025-11-11 | Option exercise · Stock option (right to buy) 10b5-1 | −500 | 16,103 | D | ||
| Juvenal Tobin W Chief Commercial Officer | 2025-11-12 | Option exercise · Stock option (right to buy) 10b5-1 | −200 | 15,903 | D | ||
| Open-market sales · 700 sh · avg $35.39 · $24,775 | |||||||
Loading xslF345X05/wk-form4a_1763154587.xml…